Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
| Location: | Maryland |
|---|---|
| Posted: | Sep 23, 2026 |
| Due: | Oct 23, 2026 |
| Agency: | DEPT OF DEFENSE |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | HT9427-26-R-E020 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Solicitation (Original)
- Original Published Date: Sep 23, 2026 09:01 am EDT
- Original Date Offers Due: Oct 23, 2026 12:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Nov 07, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
-
NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
Frederick , MDUSA
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections.
This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product.
The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance).
The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022.
- MEDICAL R & D CONTRACTING DIVISION 2 808 SCHREIDER STREET
- FORT DETRICK , MD 21702
- USA
- Julie Burns
- julia.l.burns3.civ@health.mil
- Bryan Heickman
- bryan.g.heickman.civ@health.mil
- Sep 23, 2026 09:01 am EDTSolicitation (Original)
Related Document
| Sep 24, 2026 | [Solicitation (Updated)] Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination |
| Oct 19, 2026 | [Solicitation (Updated)] Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination |
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...Project: District Court Baltimore Drug Transitional Housing Ref. #: K27-0022-42 Type: Other Status... ...
Maryland Judiciary
Bid Due: 11/09/2026
...Project: District Court Baltimore Drug Transitional Housing Ref. #: K27-0022-42 Type: Other Status... ...
Maryland Courts
Bid Due: 11/09/2026
...Follow Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... Intelligence Drug Engineering ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...Follow Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 11/09/2026